Suppression of DJ-1 protein expression improved the antitumor efficacy of conventional therapeutic drugs, as this protein is involved in different pathways regulating oxidative stress as well as promoting survival, growth, and invasion of ovarian cancer cells (230–232). The gene discussed is PARK7; the disease is ovarian cancer.